Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

Assignee

• Cytlimic

Inventors

• Tomoya Miyakawa (15 patents)
• Masaaki Oka (75 patents)
• Shoichi Hazama (11 patents)
• Koji Tamada (24 patents)
• Keiko Udaka (13 patents)

View full patent text on Google Patents →